InspireMD Files 8-K: Other Events & Reg FD Disclosure

Ticker: NSPR · Form: 8-K · Filed: Oct 7, 2024 · CIK: 1433607

Inspiremd, INC. 8-K Filing Summary
FieldDetail
CompanyInspiremd, INC. (NSPR)
Form Type8-K
Filed DateOct 7, 2024
Risk Levelmedium
Pages2
Reading Time2 min
Key Dollar Amounts$0.0001
Sentimentneutral

Sentiment: neutral

Topics: 8-K, disclosure, regulation-fd

TL;DR

InspireMD filed an 8-K on 10/7/24 for 'Other Events' and Reg FD - details TBD.

AI Summary

InspireMD, Inc. filed an 8-K on October 7, 2024, to report on other events and a Regulation FD disclosure. The filing does not contain specific financial figures or details about the nature of the events disclosed.

Why It Matters

This 8-K filing indicates that InspireMD, Inc. has made disclosures to the SEC regarding significant events or information that may be material to investors.

Risk Assessment

Risk Level: medium — The filing is an 8-K for 'Other Events' and Regulation FD disclosure, which can sometimes precede significant news, but lacks specific details within this summary.

Key Players & Entities

FAQ

What specific events are being disclosed by InspireMD, Inc. in this 8-K filing?

The filing indicates 'Regulation FD Disclosure' and 'Other Events' as the items being reported, but the specific details of these events are not provided in the summary information.

When was this 8-K report filed with the SEC?

The 8-K report was filed on October 7, 2024.

What is the principal executive office address for InspireMD, Inc.?

The address of the principal executive offices is 4 Menorat Hamaor St., Tel Aviv, Israel, 6744832.

What was InspireMD, Inc.'s former company name?

InspireMD, Inc.'s former company name was Saguaro Resources, Inc.

What is the Commission File Number for InspireMD, Inc.?

The Commission File Number for InspireMD, Inc. is 001-35731.

Filing Stats: 583 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2024-10-07 07:10:30

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INSPIREMD, INC. Date: October 7, 2024 By: /s/ Craig Shore Name: Craig Shore Title: Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing